Secukinumab provides sustained PASDAS-defined remission in psoriatic arthritis and improves health-related quality of life in patients achieving remission: 2-year results from the phase III FUTURE 2 study
Coates, L C, Gladman, D D, Nash, P, FitzGerald, O, Kavanaugh, A, Kvien, T K, Gossec, L, Strand, V, Rasouliyan, L, Pricop, L, Ding, K, Jugl, S M, Gaillez, C
Published in Arthritis research & therapy (07.12.2018)
Published in Arthritis research & therapy (07.12.2018)
Get full text
Journal Article
Unmet needs in psoriatic arthritis patients receiving immunomodulatory therapy: results from a large multinational real-world study
Alten, Rieke, Conaghan, P. G., Strand, V., Sullivan, E., Blackburn, S., Tian, H., Gandhi, K., Jugl, S. M., Deodhar, A.
Published in Clinical rheumatology (01.06.2019)
Published in Clinical rheumatology (01.06.2019)
Get full text
Journal Article
Unmet needs in ankylosing spondylitis patients receiving tumour necrosis factor inhibitor therapy; results from a large multinational real-world study
Deodhar, A, Strand, V, Conaghan, P G, Sullivan, E, Blackburn, S, Tian, H, Gandhi, K, Jugl, S M, Alten, R
Published in BMC rheumatology (02.03.2020)
Published in BMC rheumatology (02.03.2020)
Get full text
Journal Article
THU0442 Reduction in Fatigue in Patients with Active Psoriatic Arthritis Are Sustained over 2 Years: Long-Term Results of Two Phase 3 Studies with Secukinumab
Gossec, L., Kvien, T.K., Conaghan, P.G., Østergaard, M., Cañete, J., Gaillez, C., Mpofu, S., Davenport, E., Jugl, S.
Published in Annals of the rheumatic diseases (01.06.2016)
Published in Annals of the rheumatic diseases (01.06.2016)
Get full text
Journal Article
THU0630 Treatment Failure, Treatment Switching and Health-Related Quality of Life in Patients with Ankylosing Spondylitis or Psoriatic Arthritis: Results from A Large Multinational Real-World Sample in Europe and The USA
Alten, R., Strand, V., Conaghan, P.G., Deodhar, A., Sullivan, E., Blackburn, S., Tian, H., Gandhi, K., Jugl, S.
Published in Annals of the rheumatic diseases (01.06.2016)
Published in Annals of the rheumatic diseases (01.06.2016)
Get full text
Journal Article
SAT0390 Secukinumab for The Treatment of Ankylosing Spondylitis: Comparative Effectiveness Results versus Currently Licensed Biologics from A Network Meta-Analysis
Baeten, D., Mease, P., Strand, V., McInnes, I., Thom, H., Kanters, S., Palaka, E., Gandhi, K., Richards, H., Jugl, S.
Published in Annals of the rheumatic diseases (01.06.2016)
Published in Annals of the rheumatic diseases (01.06.2016)
Get full text
Journal Article
THU0448 Secukinumab for The Treatment of Psoriatic Arthritis: Comparative Effectiveness Results versus Adalimumab Up To 48 Weeks Using A Matching-Adjusted Indirect Comparison
Nash, P., McInnes, I.B., Mease, P., Thom, H., Cure, S., Palaka, E., Gandhi, K., Mpofu, S., Jugl, S.
Published in Annals of the rheumatic diseases (01.06.2016)
Published in Annals of the rheumatic diseases (01.06.2016)
Get full text
Journal Article
THU0411 Fatigue in Patients with Ankylosing Spondylitis and Low Vitality in Those with Psoriatic Arthritis: Results from A Large Real-World Survey in Europe and The USA
Conaghan, P.G., Deodhar, A., Strand, V., Alten, R., Sullivan, E., Blackburn, S., Tian, H., Gandhi, K., Jugl, S.
Published in Annals of the rheumatic diseases (01.06.2016)
Published in Annals of the rheumatic diseases (01.06.2016)
Get full text
Journal Article
OP0114 Secukinumab for The Treatment of Ankylosing Spondylitis: Comparative Effectiveness Results versus Adalimumab Using A Matching-Adjusted Indirect Comparison
Maksymowych, W., Strand, V., Baeten, D., Nash, P., Thom, H., Cure, S., Palaka, E., Gandhi, K., Richards, H., Jugl, S.
Published in Annals of the rheumatic diseases (01.06.2016)
Published in Annals of the rheumatic diseases (01.06.2016)
Get full text
Journal Article
THU0437 Secukinumab for The Treatment of Psoriatic Arthritis: Comparative Effectiveness Results versus Licensed Biologics and Apremilast from A Network Meta-Analysis
McInnes, I.B., Nash, P., Ritchlin, C., Thom, H., Kanters, S., Palaka, E., Gandhi, K., Mpofu, S., Jugl, S.
Published in Annals of the rheumatic diseases (01.06.2016)
Published in Annals of the rheumatic diseases (01.06.2016)
Get full text
Journal Article
SAT0421 Reduction in Fatigue in Patients with Active Ankylosing Spondylitis: Results of Two Phase 3 Studies of Secukinumab
Kvien, T.K., Conaghan, P.G., Deodhar, A., Gossec, L., Østergaard, M., Cañete, J., Gandhi, K., Richards, H., Williams, N., Jugl, S.
Published in Annals of the rheumatic diseases (01.06.2016)
Published in Annals of the rheumatic diseases (01.06.2016)
Get full text
Journal Article
Secukinumab provides rapid and persistent relief in pain and fatigue symptoms in patients with ankylosing spondylitis irrespective of baseline C-reactive protein levels or prior tumour necrosis factor inhibitor therapy: 2-year data from the MEASURE 2 study
Deodhar, Atul, Conaghan, Philip G, Kvien, Tore K, Strand, Vibeke, Sherif, Bintu, Porter, Brian, Jugl, Steffen M, Gandhi, Kunal K
Published in Clinical and experimental rheumatology (01.03.2019)
Get full text
Published in Clinical and experimental rheumatology (01.03.2019)
Journal Article
SAT0480 Comparative effectiveness of secukinumab and infliximab in psoriatic arthritis assessed by matching-adjusted indirect comparison using pivotal phase 3 clinical trial data
Strand, V, McInnes, I, Mease, P, Choy, E, Nash, P, Thom, H, Kalyvas, C, Gandhi, K, Pricop, L, Jugl, S
Published in Annals of the rheumatic diseases (01.06.2017)
Published in Annals of the rheumatic diseases (01.06.2017)
Get full text
Journal Article
AB0707 Comparative effectiveness of secukinumab and golimumab in ankylosing spondylitis assessed by matching-adjusted indirect comparison using pivotal phase 3 clinical trial data
Maksymowych, W, Choy, E, Yazici, Y, Walsh, J, Thom, H, Kalyvas, C, Fox, T, Gandhi, K, Jugl, S
Published in Annals of the rheumatic diseases (01.06.2017)
Published in Annals of the rheumatic diseases (01.06.2017)
Get full text
Journal Article
OP0107 Pain still remains a high unmet need among psoriatic arthritis patients receiving existing biologic treatment: results from a multi national real-world survey
Conaghan, PG, Strand, V, Alten, R, Sullivan, E, Blackburn, S, Huneault, L, Tian, H, Gandhi, K, Jugl, S
Published in Annals of the rheumatic diseases (01.06.2017)
Published in Annals of the rheumatic diseases (01.06.2017)
Get full text
Journal Article
AB0765 Secukinumab provides sustained improvement in function, quality of life and fatigue over 2 years in patients who achieved disease activity index for psoriatic arthritis (DAPSA) remission
Smolen, JS, McInnes, IB, Gossec, L, Strand, V, Pricop, L, Fox, T, Jugl, S, Gaillez, C
Published in Annals of the rheumatic diseases (01.06.2017)
Published in Annals of the rheumatic diseases (01.06.2017)
Get full text
Journal Article